[Prospectives on cancer treatment in the future--from its clinical aspects].
Remarkable progress has been achieved in the treatment of gastric cancer during these three decades, the late survival rate being increased twice or more. The factors attributing to this result were analyzed and prospect for further progress was discussed. One of the most promising ways for this purpose lies in the development of multidisciplinary treatment. So far the mode of thinking has been placed on the organ-oriented basis. However, the search should be directed to the treatment specifically effective to each biological type involved in the tumor. A concept of "Type-Oriented Treatment" was proposed herein.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005743:Gastrectomy; D006801:Humans; D008197:Lymph Node Excision; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D013274:Stomach Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D005641:Tegafur / Q000008:administration & dosage
D008937:Mitomycins; D005641:Tegafur; D016685:Mitomycin